Where clinical trials are planned for the Janssen, Sinovac and ...
Philstar.com - 23 Jan 2021Belgium-based firm Janssen Pharmaceutica and Chinese drugmakers Sinovac Biotech and Clover Biopharmaceuticals have secured approval from the ...
Clover vaccine
Belgium-based firm Janssen Pharmaceutica and Chinese drugmakers Sinovac Biotech and Clover Biopharmaceuticals have secured approval from the ...
Gavi terminates COVID vaccine deal with Clover, demands $224M repayment
Fierce Pharma - 24 Mar 2025Gavi terminates COVID vaccine deal with Clover, demands $224M repayment ...
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019 - Vietnam Investment Review
VIR - 24 Mar 2025Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019 ...
Dispute over Covid vaccines casts doubt on Clover Bio recovery
Bamboo Works - 03 Apr 2025Dispute over Covid vaccines casts doubt on Clover Bio recovery ...
Clover's RSV vaccine shows mettle in early-stage face-off with GSK's Arexvy
FirstWord Pharma - 28 Oct 2024Clover's RSV vaccine shows mettle in early-stage face-off with GSK's Arexvy ...
Another Injectable Toxoid Vaccine Flops for C. Diff
MedPage Today - 28 Aug 2024Another Injectable Toxoid Vaccine Flops for C. Diff ...
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY
Olean Times Herald - 28 Oct 2024Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY ...
Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY
Salamanca Press - 28 Oct 2024Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY ...
Bribery past hounds Chinese firm eyeing PH market for coronavirus vaccines
Inquirer.net - 07 Dec 2020Bribery past hounds Chinese firm eyeing PH market for coronavirus vaccines ...
CEPI extends partnership with Clover to fund COVID-19 vaccine candidate through global Phase 2/3 study to licensure
CEPI - 02 Nov 2020CEPI extends partnership with Clover to fund COVID-19 vaccine candidate through global Phase 2/3 study to licensure ...
Bivalent RSV Vaccine Candidate For Young Adults Demonstrates Neutralizing Antibody Responses
Vax-Before-Travel - 08 Apr 2024Bivalent RSV Vaccine Candidate For Young Adults Demonstrates Neutralizing Antibody Responses ...
Covid-19 vaccines in PH: What to know
Philippine News Agency - 08 Jan 2021Covid-19 vaccines in PH: What to know ...
Russia's Gamaleya applies for emergency vaccine use in Philippines
Reuters - 08 Jan 2021Russia's Gamaleya applies for emergency vaccine use in Philippines ...
Companies set to ramp up COVID-19 vaccine production following plan for second booster shots
Global Times - 15 Dec 2022Companies set to ramp up COVID-19 vaccine production following plan for second booster shots ...
Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys
News-Medical - 28 Sep 2020Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys ...
CEPI and Clover expand partnership for COVID-19 vaccine to include evaluation as a booster
CEPI - 17 Nov 2021CEPI and Clover expand partnership for COVID-19 vaccine to include evaluation as a booster ...
CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate
CEPI - 06 Jul 2020CEPI expands partnership with Clover Biopharmaceuticals to rapidly advance development and manufacture of COVID-19 vaccine candidate ...
From lab to potential jab: Clover's COVID-19 vaccine story
CEPI - 30 Jun 2021From lab to potential jab: Clover's COVID-19 vaccine story ...
Clover Biopharmaceuticals announces positive efficacy data from Phase 2/3 trial
CEPI - 21 Sep 2021Clover Biopharmaceuticals announces positive efficacy data from Phase 2/3 trial ...
CEPI-funded COVID-19 vaccine candidates progress to clinical trials
CEPI - 22 Jun 2020CEPI-funded COVID-19 vaccine candidates progress to clinical trials ...